Stryker NTX registry

Not Applicable

Completed

• Conditions: Osteoarthritis, rheumatoid arthritis, avascular necrosis, traumatic arthritis or other diseases requiring total knee arthroplasty or partial knee resurfacing.; Musculoskeletal Diseases; Arthrosis, unspecified

• Registration Number: ISRCTN17022568
• Lead Sponsor: Stryker European Operations BV (Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-03-22
• Study Completion: 2021-03-25
• Last Update Posted: 30 March 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1600

Inclusion Criteria

1. Patients requiring primary Total Knee Arthroplasty (TKA), suitable for the use of the Scorpio NRG with X3 insert or Triathlon Total Knee System with X3 insert, or, patients requiring partial knee resurfacing (unicompartmental knee) suitable for the use of the Triathlon PKR (Partial Knee Resurfacing) System with X3 insert
2. Patients who understand the conditions of the outcomes registry and are willing and able to comply with the standard post-operative evaluations and the prescribed rehabilitation
3. Patients who signed the Informed Consent Form (approved by Ethics Committee if required) prior to surgery

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Survivorship of the implant; pre-operative, intra-operative and 1 year, 3 years, 5 years, 7 years and 10 years follow-up

Secondary Outcome Measures

Name	Time	Method
<br> 1. Any adverse event<br> 2. Knee Society Score (KSS)<br> 3. Knee Injury and Osteoarthritis Outcome Score (KOOS)<br> 4. EuroQol Group Score (EQ5D)<br> Pre-operative, intra-operative and 1 year, 3 years, 5 years, 7 years and 10 years follow-up<br>